Hi & Fi Asia-China 2024 live: Personalized nutraceuticals drive biotics space in China
21 Jun 2024 | Novonesis
Novonesis is continuing to grow its probiotics business in China alongside its HMO prebiotics. The expanding “biotics” space is being driven by a desire for more personalized nutrition solutions, says Jakob Dalmose Rasmussen, VP of Human Health Biosolutions at Novonesis. He shares insights into the Chinese market and introduces a product being launched exclusively in the country — SmartGuard for kids.
More videos